201 related articles for article (PubMed ID: 33721435)
1. Therapeutic effect of thalidomide combined with temozolomide and three-dimensional conformal radiotherapy for patients with high-grade gliomas after operation.
Sui L; Li Y; Xu Z; Shen X
J BUON; 2021; 26(1):2608-2615. PubMed ID: 33721435
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of thalidomide combined with temozolomide and three-dimensional conformal radiotherapy for patients with high-grade gliomas after operation.
Sui L; Li Y; Xu Z; Shen X
J BUON; 2020; 25(6):2608-2615. PubMed ID: 33455103
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide chemotherapy combined with radiotherapy versus radiotherapy alone after surgery in patients with high-risk low-grade gliomas.
Hou Y; Huan Y; Zhang Y; Liu X; Li Y
J BUON; 2021; 26(3):977-983. PubMed ID: 34268962
[TBL] [Abstract][Full Text] [Related]
4. Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study.
Wang J; Yan L; Ai P; He Y; Guan H; Wei Z; He L; Mu X; Liu Y; Peng X
Neurosurg Rev; 2021 Jun; 44(3):1447-1455. PubMed ID: 32529528
[TBL] [Abstract][Full Text] [Related]
5. Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report.
Balducci M; Apicella G; Manfrida S; Mangiola A; Fiorentino A; Azario L; D'Agostino GR; Frascino V; Dinapoli N; Mantini G; Albanese A; de Bonis P; Chiesa S; Valentini V; Anile C; Cellini N
Strahlenther Onkol; 2010 Oct; 186(10):558-64. PubMed ID: 20936460
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of 3-dimensional conformal radiotherapy combined with temozolomide for glioma].
Wang L; Tu Q; Zhou W; Zhou R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1106-10. PubMed ID: 22169729
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of transcatheter arterial chemoembolization combined with 125I seed implantation and three-dimensional conformal radiotherapy in advanced primary hepatocellular carcinoma.
Zhang H; Yang A; Zhang J
J BUON; 2020; 25(2):952-958. PubMed ID: 32521891
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of bevacizumab combined with temozolomide dose-dense regimen on recurrent glioma.
Li J; Huang W; Piao M; Liu Z; Ji S; Xue J; Zhu X
J BUON; 2021; 26(1):145-151. PubMed ID: 33721445
[TBL] [Abstract][Full Text] [Related]
9. [Combination of transrectal 125I seeds implantation brachytherapy and intermittent hormonal therapy for locally advanced prostate cancer].
Wu HM; Lü J; Hu WL; Zhang JH; Wang W; Xiao YS; Wang NX; Ran JW; Huang XD
Zhonghua Nan Ke Xue; 2013 Jul; 19(7):617-21. PubMed ID: 23926678
[TBL] [Abstract][Full Text] [Related]
10. Surgery, radiotherapy and temozolomide in treating high-grade gliomas.
Parlato C; Barbarisi M; Moraci M; Moraci A
Front Biosci; 2006 May; 11():1280-3. PubMed ID: 16368514
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of brachytherapy combined with endocrine therapy and external beam radiotherapy in the treatment of intermediate and high-risk localized prostate cancer.
Zhang W; Zhou H; Qin M; Zhang X; Zhang J; Chai S; Song J
J BUON; 2020; 25(5):2405-2411. PubMed ID: 33277862
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.
Zelefsky MJ; Wallner KE; Ling CC; Raben A; Hollister T; Wolfe T; Grann A; Gaudin P; Fuks Z; Leibel SA
J Clin Oncol; 1999 Feb; 17(2):517-22. PubMed ID: 10080594
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study.
Kim YH; Park CK; Cho WH; Kim IA; Moon S; Choe G; Park SH; Kim IH; Kim DG; Jung HW; Lee MM; Bae SH; Cha SH; Kim CY
J Neurooncol; 2011 Jul; 103(3):503-12. PubMed ID: 20862518
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Forsythe K; Blacksburg S; Stone N; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
[TBL] [Abstract][Full Text] [Related]
15. Clinical observation of three dimensional conformal radiotherapy with tamoxifen in treatment of postoperative malignant glioma.
Zhou SB; Liu YC; Yin XX; Ding WX; Guo XW; Gu L; Huang XE
Asian Pac J Cancer Prev; 2015; 16(5):1743-5. PubMed ID: 25773819
[TBL] [Abstract][Full Text] [Related]
16. [Application of neoadjuvant hormonal therapy in (125)I permanent seed implantation for prostate cancer].
Cui X; Li Q; Xu JJ; Li J; Ou TW
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(38):2710-2. PubMed ID: 23290112
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
18. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.
Kollmeier MA; Stock RG; Stone N
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):645-53. PubMed ID: 14529768
[TBL] [Abstract][Full Text] [Related]
19. Permanent
Ding XF; Huang TB; Gao Y; Lu SM; Tao HZ; Xu JN; Xu YZ; Wang F; Zhou YQ; Zhou GC; Luan Y
Int J Urol; 2019 Feb; 26(2):278-283. PubMed ID: 30515888
[TBL] [Abstract][Full Text] [Related]
20. Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center.
Kong L; Wu J; Gao J; Qiu X; Yang J; Hu J; Hu W; Mao Y; Lu JJ
Cancer; 2020 Jun; 126(12):2802-2810. PubMed ID: 32167589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]